Can You Take Mounjaro While on Ramipril?

Mounjaro does not directly block or amplify ramipril's mechanism, but the weight loss it produces can lower blood pressure independently, creating a cumulative effect worth monitoring.
Ramipril is commonly prescribed for the same weight-related cardiovascular conditions that make someone eligible for Mounjaro in the first place, so co-prescribing is clinically familiar territory.
Dehydration from gastrointestinal side effects (nausea, vomiting, diarrhoea) can raise the risk of low blood pressure and kidney stress when taking ACE inhibitors — staying well hydrated matters more than usual.
Any change to either medicine (starting, stopping, or changing the dose) should be discussed with your prescriber first; never adjust ramipril independently based on home blood pressure readings alone.

Taking Mounjaro while on ramipril is not automatically ruled out, and many people with high blood pressure are prescribed both. Ramipril is an ACE inhibitor used to manage hypertension; Mounjaro (tirzepatide) is a prescription-only weight-loss and diabetes medicine. The key consideration is that as Mounjaro produces weight loss, your blood pressure often falls too, which may mean your ramipril dose needs reviewing by your prescriber. These are prescription-only medicines and any combination requires clinical assessment — your prescriber is the right person to weigh up your individual picture before any change is made.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What your prescriber weighs up when both medicines are in the picture

Does Mounjaro interact directly with ramipril?

There is no established pharmacokinetic interaction between tirzepatide and ramipril, meaning one does not alter how the other is absorbed, distributed or cleared. Mounjaro works on GIP and GLP-1 receptors involved in appetite regulation and blood-sugar control; ramipril works on the renin-angiotensin system to relax blood vessels. Their mechanisms sit on separate pathways.

That said, "no direct drug interaction" does not mean the two medicines can be ignored in combination. The clinical concern is indirect. Mounjaro produces meaningful weight loss in most people who respond to it, and losing 10–20% of body weight has a measurable blood-pressure-lowering effect of its own. If your ramipril dose was calibrated to your pre-treatment blood pressure, it may become a higher dose than you need once treatment is established. The result can be symptomatic low blood pressure (dizziness on standing, light-headedness, fatigue) which is worth flagging to your prescriber rather than dismissing as a Mounjaro side effect.

You can read more about tirzepatide's mechanism and licensed uses on the tirzepatide overview page, and if you want a detailed look at whether you can take Mounjaro with ramipril, that page covers the combination in full. The NHS tirzepatide medicine page covers common cautions in plain language.

Should the dehydration risk change how you manage either medicine?

This is the practical question our prescribers hear most often from people who are also taking antihypertensives. Gastrointestinal side effects (nausea, loose stools, vomiting) are the most commonly reported effects when starting Mounjaro or moving up through the dose schedule. They are usually mild and settle within a couple of weeks, but while they persist, fluid loss is real.

For someone on ramipril, dehydration matters more than it would otherwise. ACE inhibitors reduce the kidney's ability to compensate for low circulating volume; combined with a drop in blood pressure from weight loss, the result can be pre-renal impairment, the kidneys temporarily underperform because not enough blood is reaching them. Symptoms include reduced urination, unusual thirst, and a feeling of weakness beyond ordinary nausea.

The practical step is straightforward: sip water consistently through the day, especially in the first few weeks of treatment or after a dose increase. Keep your ramipril in the same place you always have (next to the kitchen tap, say) so the routine stays intact even when appetite is low. If you develop persistent vomiting or cannot keep fluids down for more than a day, that warrants a call to your GP or prescriber rather than a wait-and-see approach.

For a broader picture of what else to monitor alongside Mounjaro, the what to take while on Mounjaro page covers compatible medicines and supplements in more detail.

Will starting Mounjaro mean my ramipril dose will need to change?

Possibly, over time, though not immediately and not automatically. The blood-pressure benefit from weight loss accumulates gradually over weeks and months rather than appearing after one pen. For most people, their prescriber will want to check blood pressure readings at reviews (typically at the 3-month and 6-month mark) rather than adjusting ramipril pre-emptively.

If home monitoring shows readings consistently lower than your target range (or if you are experiencing dizziness when standing up), that is a clear prompt to contact your prescriber. It is worth knowing that some people reach a point where their cardiovascular risk factors improve enough that their antihypertensive dose can be reduced or, occasionally, withdrawn, that is not a side effect of Mounjaro but a consequence of the underlying condition improving.

Hypertension is one of the weight-related comorbidities that can make someone eligible for Mounjaro under its UK licence, so your prescriber will already be thinking about how your blood pressure picture interacts with treatment. The Mounjaro treatment page explains the eligibility criteria in full. For context on the private cost of treatment, the Mounjaro price comparison page lays out what the UK private market looks like.

What should you tell your prescriber before starting, and what should you monitor after?

Before starting Mounjaro, your prescriber needs a complete medicines list. Ramipril should be on it, alongside any other antihypertensives, diuretics or medicines affecting kidney function. This is standard practice at a registered UK pharmacy: a clinical review is not a checkbox exercise, and at nume a GPhC-registered prescriber personally reads every consultation response before anything is approved.

After starting, the things worth tracking are blood pressure readings (a home monitor is useful), any dizziness especially when moving from sitting or lying to standing, and fluid intake during periods of nausea. If you are also considering other formulations of tirzepatide, our Peptide Sciences tirzepatide page explains what that product is and how it compares. The MHRA's Yellow Card scheme is the right route for reporting unexpected effects with either medicine.

If any of this raises questions about your specific situation, speaking to a prescriber directly is more useful than further reading. You can start a free consultation and a named clinician will review your circumstances the same day.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions